Literature DB >> 28823009

Proton pump inhibitors as risk factor for metabolic syndrome and hepatic steatosis in coeliac disease patients on gluten-free diet.

Nicola Imperatore1, Raffaella Tortora2,3, Anna Testa2, Nicolò Gerbino2, Nicola Caporaso2, Antonio Rispo2.   

Abstract

BACKGROUND: Recent research has shown that patients with coeliac disease (CD) are at risk of developing metabolic syndrome (MS) and hepatic steatosis (HS) after commencing a gluten-free diet (GFD). This study aimed to evaluate the predictive factors for MS and HS in CD after 1 year of GFD.
METHODS: All consecutive newly diagnosed CD patients were enrolled. We prospectively collected data about BMI; waist circumference; blood pressure; cholesterol; triglycerides, glucose and insulin blood levels; insulin resistance (through the homeostatic model assessment HOMA-IR) and treatment with proton pump inhibitors (PPI). Diagnosis of MS was made in accordance with current guidelines and HS was diagnosed by ultrasonography. The prevalence of MS and HS was re-assessed after 1 year of GFD. A logistic regression analysis was performed to identify risk factors for MS and HS occurrence after 1 year of GFD.
RESULTS: Of 301 patients with newly diagnosed CD, 4.3% met criteria for diagnosis of MS and 25.9% presented with HS at the time of CD diagnosis; 99 subjects (32.8%) had long-term exposure to PPI during the study period. After 1 year, 72 (23.9%) patients had developed MS (4.3 vs 23.9%; p < 0.001, OR 6.9) and 112 (37.2%) had developed HS (25.9 vs 37.2%; p < 0.01, OR 1.69). At multivariate analysis, high BMI at diagnosis (OR 10.8; p < 0.001) and PPI exposure (OR 22.9; p < 0.001) were the only factors associated with the occurrence of MS; HOMA-IR (OR 9.7; p < 0.001) and PPI exposure (OR 9.2; p < 0.001) were the only factors associated with the occurrence of HS.
CONCLUSIONS: PPI exposure adds further risk of occurrence of MS and HS for patients with CD on GFD. The use of PPI in patients with CD on GFD should be limited to strict indications.

Entities:  

Keywords:  Coeliac disease; Hepatic steatosis; Metabolic syndrome; Proton pump inhibitors

Mesh:

Substances:

Year:  2017        PMID: 28823009     DOI: 10.1007/s00535-017-1381-7

Source DB:  PubMed          Journal:  J Gastroenterol        ISSN: 0944-1174            Impact factor:   7.527


  42 in total

1.  ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD: the Task Force on diabetes, pre-diabetes, and cardiovascular diseases of the European Society of Cardiology (ESC) and developed in collaboration with the European Association for the Study of Diabetes (EASD).

Authors:  Lars Rydén; Peter J Grant; Stefan D Anker; Christian Berne; Francesco Cosentino; Nicolas Danchin; Christi Deaton; Javier Escaned; Hans-Peter Hammes; Heikki Huikuri; Michel Marre; Nikolaus Marx; Linda Mellbin; Jan Ostergren; Carlo Patrono; Petar Seferovic; Miguel Sousa Uva; Marja-Riita Taskinen; Michal Tendera; Jaakko Tuomilehto; Paul Valensi; Jose Luis Zamorano; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Guy De Backer; Per Anton Sirnes; Eduardo Alegria Ezquerra; Angelo Avogaro; Lina Badimon; Elena Baranova; Helmut Baumgartner; John Betteridge; Antonio Ceriello; Robert Fagard; Christian Funck-Brentano; Dietrich C Gulba; David Hasdai; Arno W Hoes; John K Kjekshus; Juhani Knuuti; Philippe Kolh; Eli Lev; Christian Mueller; Ludwig Neyses; Peter M Nilsson; Joep Perk; Piotr Ponikowski; Zeljko Reiner; Naveed Sattar; Volker Schächinger; André Scheen; Henrik Schirmer; Anna Strömberg; Svetlana Sudzhaeva; Juan Luis Tamargo; Margus Viigimaa; Charalambos Vlachopoulos; Robert G Xuereb
Journal:  Eur Heart J       Date:  2013-08-30       Impact factor: 29.983

2.  World Gastroenterology Organisation Global Guidelines: GERD Global Perspective on Gastroesophageal Reflux Disease.

Authors:  Richard Hunt; David Armstrong; Peter Katelaris; Mary Afihene; Abate Bane; Shobna Bhatia; Min-Hu Chen; Myung Gyu Choi; Angelita Cristine Melo; Kwong Ming Fock; Alex Ford; Michio Hongo; Aamir Khan; Leonid Lazebnik; Greger Lindberg; Maribel Lizarzabal; Thein Myint; Joaquim Prado Moraes-Filho; Graciela Salis; Jaw Town Lin; Raj Vaidya; Abdelmounen Abdo; Anton LeMair
Journal:  J Clin Gastroenterol       Date:  2017-07       Impact factor: 3.062

3.  Impact of gluten-free diet on cardiovascular risk factors. A retrospective analysis in a large cohort of coeliac patients.

Authors:  Barbara Zanini; Elisa Mazzoncini; Francesco Lanzarotto; Chiara Ricci; Bruno M Cesana; Vincenzo Villanacci; Alberto Lanzini
Journal:  Dig Liver Dis       Date:  2013-05-18       Impact factor: 4.088

4.  Metabolic syndrome in patients with coeliac disease on a gluten-free diet.

Authors:  R Tortora; P Capone; G De Stefano; N Imperatore; N Gerbino; S Donetto; V Monaco; N Caporaso; A Rispo
Journal:  Aliment Pharmacol Ther       Date:  2015-01-08       Impact factor: 8.171

5.  An obesity-associated gut microbiome with increased capacity for energy harvest.

Authors:  Peter J Turnbaugh; Ruth E Ley; Michael A Mahowald; Vincent Magrini; Elaine R Mardis; Jeffrey I Gordon
Journal:  Nature       Date:  2006-12-21       Impact factor: 49.962

Review 6.  Toll-like receptors in alcoholic liver disease, non-alcoholic steatohepatitis and carcinogenesis.

Authors:  Yoon Seok Roh; Ekihiro Seki
Journal:  J Gastroenterol Hepatol       Date:  2013-08       Impact factor: 4.029

Review 7.  Cardiovascular disease in patients with coeliac disease: A systematic review and meta-analysis.

Authors:  Louise Emilsson; Benjamin Lebwohl; Johan Sundström; Jonas F Ludvigsson
Journal:  Dig Liver Dis       Date:  2015-06-16       Impact factor: 4.088

8.  Proton Pump Inhibitor Usage and the Risk of Myocardial Infarction in the General Population.

Authors:  Nigam H Shah; Paea LePendu; Anna Bauer-Mehren; Yohannes T Ghebremariam; Srinivasan V Iyer; Jake Marcus; Kevin T Nead; John P Cooke; Nicholas J Leeper
Journal:  PLoS One       Date:  2015-06-10       Impact factor: 3.240

9.  2013 ESH/ESC guidelines for the management of arterial hypertension: the Task Force for the Management of Arterial Hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC).

Authors:  Giuseppe Mancia; Robert Fagard; Krzysztof Narkiewicz; Josep Redon; Alberto Zanchetti; Michael Böhm; Thierry Christiaens; Renata Cifkova; Guy De Backer; Anna Dominiczak; Maurizio Galderisi; Diederick E Grobbee; Tiny Jaarsma; Paulus Kirchhof; Sverre E Kjeldsen; Stéphane Laurent; Athanasios J Manolis; Peter M Nilsson; Luis Miguel Ruilope; Roland E Schmieder; Per Anton Sirnes; Peter Sleight; Margus Viigimaa; Bernard Waeber; Faiez Zannad; Josep Redon; Anna Dominiczak; Krzysztof Narkiewicz; Peter M Nilsson; Michel Burnier; Margus Viigimaa; Ettore Ambrosioni; Mark Caufield; Antonio Coca; Michael Hecht Olsen; Roland E Schmieder; Costas Tsioufis; Philippe van de Borne; Jose Luis Zamorano; Stephan Achenbach; Helmut Baumgartner; Jeroen J Bax; Héctor Bueno; Veronica Dean; Christi Deaton; Cetin Erol; Robert Fagard; Roberto Ferrari; David Hasdai; Arno W Hoes; Paulus Kirchhof; Juhani Knuuti; Philippe Kolh; Patrizio Lancellotti; Ales Linhart; Petros Nihoyannopoulos; Massimo F Piepoli; Piotr Ponikowski; Per Anton Sirnes; Juan Luis Tamargo; Michal Tendera; Adam Torbicki; William Wijns; Stephan Windecker; Denis L Clement; Antonio Coca; Thierry C Gillebert; Michal Tendera; Enrico Agabiti Rosei; Ettore Ambrosioni; Stefan D Anker; Johann Bauersachs; Jana Brguljan Hitij; Mark Caulfield; Marc De Buyzere; Sabina De Geest; Geneviève Anne Derumeaux; Serap Erdine; Csaba Farsang; Christian Funck-Brentano; Vjekoslav Gerc; Giuseppe Germano; Stephan Gielen; Herman Haller; Arno W Hoes; Jens Jordan; Thomas Kahan; Michel Komajda; Dragan Lovic; Heiko Mahrholdt; Michael Hecht Olsen; Jan Ostergren; Gianfranco Parati; Joep Perk; Jorge Polonia; Bogdan A Popescu; Zeljko Reiner; Lars Rydén; Yuriy Sirenko; Alice Stanton; Harry Struijker-Boudier; Costas Tsioufis; Philippe van de Borne; Charalambos Vlachopoulos; Massimo Volpe; David A Wood
Journal:  Eur Heart J       Date:  2013-06-14       Impact factor: 29.983

10.  Association of Proton Pump Inhibitor (PPI) Use with Energy Intake, Physical Activity, and Weight Gain.

Authors:  Jennifer L Czwornog; Gregory L Austin
Journal:  Nutrients       Date:  2015-10-19       Impact factor: 5.717

View more
  6 in total

1.  Will Proton Pump Inhibitors Increase the Risk of Diabetes Mellitus? A Systemic Review and Meta-Analysis.

Authors:  Yue Chen; Lei Hu; Chenyu Sun; Jiantong Bao; Jie Liu; Chandur Bhan; Keun Young Kim; Raveena Manem; Pratikshya Thapa; Shaodi Ma; Mengqing Liu; Xingyu Cheng; Ce Cheng; Qin Zhou
Journal:  Turk J Gastroenterol       Date:  2022-06       Impact factor: 1.555

2.  Bi-directional Relationship Between Celiac Disease and Liver Chemistries: A Systematic Review and Meta-Analysis.

Authors:  Manik Aggarwal; Rajat Garg; Prabhat Kumar; Christina C Lindenmeyer; Jamile Wakim-Fleming; Claire Jansson-Knodell; Alberto Rubio-Tapia
Journal:  Dig Dis Sci       Date:  2022-08-24       Impact factor: 3.487

Review 3.  Multidimensional Disadvantages of a Gluten-Free Diet in Celiac Disease: A Narrative Review.

Authors:  Martyna Marciniak; Aleksandra Szymczak-Tomczak; Dagmara Mahadea; Piotr Eder; Agnieszka Dobrowolska; Iwona Krela-Kaźmierczak
Journal:  Nutrients       Date:  2021-02-16       Impact factor: 5.717

4.  Regular use of proton-pump inhibitors and risk of stroke: a population-based cohort study and meta-analysis of randomized-controlled trials.

Authors:  Man Yang; Qiangsheng He; Fang Gao; Krish Nirantharakumar; Tonny Veenith; Xiwen Qin; Amy T Page; Martin C S Wong; Junjie Huang; Zi Chong Kuo; Bin Xia; Changhua Zhang; Yulong He; Wenbo Meng; Jinqiu Yuan; Yihang Pan
Journal:  BMC Med       Date:  2021-12-03       Impact factor: 8.775

5.  PNPLA3 rs738409 Polymorphism Predicts Development and Severity of Hepatic Steatosis but Not Metabolic Syndrome in Celiac Disease.

Authors:  Raffaella Tortora; Antonio Rispo; Anna Alisi; Nicola Imperatore; Annalisa Crudele; Francesca Ferretti; Valerio Nobili; Luca Miele; Nicolò Gerbino; Nicola Caporaso; Filomena Morisco
Journal:  Nutrients       Date:  2018-09-05       Impact factor: 5.717

6.  Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?

Authors:  Francesco Tovoli; Chiara Faggiano; Alberto Raiteri; Alice Giamperoli; Teresa Catenaro; Vito Sansone; Dante Pio Pallotta; Alessandro Granito
Journal:  Nutrients       Date:  2022-03-14       Impact factor: 5.717

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.